Helus Pharma Inc. logo

Helus Pharma Inc.

HELP | NASDAQ
Chart Builder DCF Calculator
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.77
+$0.17 (+1.60%)
Pre-market: Nov 2, 2026, 7:09 AM ET
Fiscal Year
Period Ending
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
FY 2021
Mar 31, 2021
Cash & Equivalents
157.78M 135.02M 208.99M 16.63M 53.64M 64.03M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a 242K n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a
Receivables
5.03M 5.89M 4.48M 3.05M 2.1M 1.33M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
n/a 2.91M 2.18M 1.77M 1.34M n/a
Total Current Assets
185.11M 165.97M 218.54M 23.19M 58.36M 66.48M
Property-Plant & Equipment
195.64K 141K 547K 450K 491K 557K
Goodwill & Intangibles
66.67M 92.51M 82.94M 30.26M 24.98M 25.07M
Total Long-Term Assets
66.86M 92.65M 83.49M 30.71M 25.71M 25.63M
Total Assets
251.98M 258.62M 302.02M 53.9M 84.06M 92.11M
Account Payables
n/a 21.42M 9.81M 5.66M 5.26M 2.79M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
19.44M n/a 9.81M n/a n/a n/a
Total Current Liabilities
19.44M 21.42M 10.1M 5.66M 7.91M 4.9M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a 1.09M
Total Long-Term Liabilities
n/a n/a n/a n/a n/a 1.09M
Total Liabilities
19.44M 21.42M 10.1M 5.66M 7.91M 5.99M
Total Debt
n/a n/a 291K n/a n/a n/a
Book Value
232.54M 237.2M 291.93M 48.23M 76.16M 86.12M
Book Value Per Share
6.68 11.73 14.60 9.88 17.30 32.72
Common Stock
493.72M 464.36M 443.88M 158.16M 141.45M 100.68M
Retained Earnings
-390.82M -339.37M -226.23M -148.15M -100.66M -33.03M
Comprehensive Income
8.08M -7.23M -2.29M -2.04M -366K 24K
Shareholders Equity
232.24M 237.2M 291.93M 48.23M 76.16M 86.12M
Total Investments
n/a n/a n/a n/a 242K n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.